The OPTIMA Study: Assessing a New Cinacalcet (Sensipar/Mimpara) Treatment Algorithm for Secondary Hyperparathyroidism

Background and objectives: Cinacalcet, a novel calcimimetic, targets the calcium-sensing receptor to lower parathyroid hormone (PTH), calcium, and phosphorus levels in dialysis patients with secondary hyperparathyroidism (SHPT). This study compared the efficacy of a cinacalcet-based regimen with unr...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Messa, Piergiorgio, Macário, Fernando, Yaqoob, Magdi, Bouman, Koen, Braun, Johann, von Albertini, Beat, Brink, Hans, Maduell, Francisco, Graf, Helmut, Frazão, João M., Bos, Willem Jan, Torregrosa, Vicente, Saha, Heikki, Reichel, Helmut, Wilkie, Martin, Zani, Valter J., Molemans, Bart, Carter, Dave, Locatelli, Francesco
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2008
Pynciau:
Clinical Nephrology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2390975/
https://ncbi.nlm.nih.gov/pubmed/18178780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03591006
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg